Product Information
VENLAFAXINE HCL 25 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0785 per EA under NDC 00093914701. Its NADAC has been published 316 times since Jun 17, 2020.
Strength
25 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093914701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076690On Market Since
8/4/2006
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 25 MG TABLET has been published 316 times since Jun 17, 2020, and over the history we have for it it has declined 44.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0785 per EA |
|---|---|
| All-time high | $0.2387 (Aug 11, 2021) |
| All-time low | $0.0488 (Jul 17, 2024) |
| 52-week high | $0.0835 |
| 52-week low | $0.0558 |
| Median price | $0.0772 |
| Average price | $0.0979 |
| Largest weekly change | +94.5% (Aug 19, 2020) |
| Weeks tracked | 316 |
| Tracking since | Jun 17, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 25 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0785 per EA (NDC 00093914701), effective Jul 1, 2026.
How has the price of VENLAFAXINE HCL 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 25 MG TABLET has declined 44.9%. It has been tracked across 316 weekly CMS publications since Jun 17, 2020.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 25 MG TABLET?
Since Jun 17, 2020, the NADAC for VENLAFAXINE HCL 25 MG TABLET has ranged from a low of $0.0488 (Jul 17, 2024) to a high of $0.2387 (Aug 11, 2021), with a median of $0.0772 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as VENLAFAXINE HCL 25 MG TABLET, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 25 MG TABLET?
VENLAFAXINE HCL 25 MG TABLET (NDC 00093914701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification